NewAmsterdam Pharma N.V.

NASDAQ: NAMS · Real-Time Price · USD
25.06
-0.11 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
24.69
-1.48%
After-hours: Aug 15, 2025, 06:42 PM EDT

NewAmsterdam Pharma Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-10.04 -5.19 -9.78 -4.71
PEG Ratio
-0.53 -0.06 0.15 -0.02
PS Ratio
53.22 71.91 2.16 n/a
PB Ratio
3.20 3.18 0.43 3.48
P/FCF Ratio
-15.23 -6.5 25.97 -6.87
P/OCF Ratio
-15.29 -6.5 25.93 -6.88
OCF/S Ratio
-3.48 -11.06 0.08 n/a
Debt / Equity Ratio
0.00 0.00 0.00 0.00
Quick Ratio
8.08 6.95 12.64 5.96
Current Ratio
8.08 6.95 12.64 5.96
Asset Turnover
0.05 0.04 0.18 n/a
Interest Coverage
n/a -24.38 n/a n/a
Return on Equity
-0.32 -0.61 -0.04 -0.74
Return on Assets
-0.28 -0.51 -0.04 -0.61
Return on Invested Capital
-0.23 -0.56 -0.01 -0.62
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00 n/a
Net Profit Margin
-5.3 -13.86 -0.22 n/a
Pretax Profit Margin
-5.3 -12.56 -0.22 n/a
Operating Profit Margin
-3.87 -12.99 -0.03 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-5.3 -13.86 -0.03 n/a